Pfizer to buy Array BioPharma in $11.4 billion deal
NEW YORK -- Pfizer is buying the cancer treatment company Array BioPharma in a deal valued at $11.4 billion. |!| Fort Wayne
NEW YORK -- Pfizer is buying the cancer treatment company Array BioPharma in a deal valued at $11.4 billion. |!| Fort Wayne